JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Effect of First Line Gastric Cancer Chemotherapy Regime on the AGS Cell Line - MTT Assay Results
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Effect of First Line Gastric Cancer Chemotherapy Regime on the AGS Cell Line - MTT Assay Results
Alizadeh-Navaei, Reza; Rafiei, Alireza; Abedian-Kenari, Saeid; Asgarian-Omran, Hossein; Valadan, Reza; Hedayatizadeh-Omran, Akbar;
  PDF(new window)
 Abstract
Background: Combination chemotherapy regimes are common treatments for cancer. The aim of this study was to evaluation the effect of individual chemotherapeutic agents in comparison with a first line chemotherapy regime treatment in the AGS gastric cancer cell line by MTT assay. Materials and Methods: In this experimental study, AGS cells were grown in RPMI-1640 supplemented with 10% fetal calf serum and 100 IU/ml penicillin, and streptomycinin, under a humidified condition at with 5% CO2. All cells were washed with PBS and detached with trypsin, centrifuged and 8000 cells re-plated on to 96- well plates. LD50 doses of Epirubicin, Cisplatin and 5-fluorouracil were added to each well in mono or triple therapy. Anti-proliferative activities were determined by MTT assay after 24, 48 or 72 h. Results: Results of MTT assays showed that there were no significant differences among 3 drugs in monotherapy (p
 Keywords
Gastric cancer;chemotherapy;AGS cell line;MTT;monotherapy;combined therapy;
 Language
English
 Cited by
1.
Evaluating Direct Costs of Gastric Cancer Treatment in Iran - Case Study in Kerman City in 2015,;;;;

Asian Pacific Journal of Cancer Prevention, 2016. vol.17. 6, pp.3007-3013
 References
1.
Ajani JA, Moiseyenko VM, Tjulandin S, et al (2007). Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group. J Clin Oncol, 25, 3205-9. crossref(new window)

2.
Armstrong B, Doll R (1975). Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer, 15, 617-31. crossref(new window)

3.
Arnold M, Moore SP, Hassler S, et al (2014). The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut, 63, 64-71. crossref(new window)

4.
Benson AB (2008). Advanced gastric cancer: an update and future directions. Gastrointest Cancer Res, 2, 47-53.

5.
Brenner H, Rothenbacher D, Arndt V (2009). Epidemiology of stomach cancer. Methods Mol Biol, 472, 467-77. crossref(new window)

6.
Choi YY, Noh SH, Cheong JH (2015). Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J, 56, 1177-85. crossref(new window)

7.
Guedes MT, de Jesus JP, de Souza Filho O, et al (2014). Clinical and epidemiological profile of cases of deaths from stomach cancer in the National Cancer Institute, Brazil. Ecancermedicalscience, 8, 445.

8.
Kim YH (2005). Chemotherapy for advanced gastric cancer: slow but further progress. Cancer Res Treat, 37, 79-86. crossref(new window)

9.
Lin X, Zhao Y, Song WM, et al (2015). Molecular classification and prediction in gastric cancer. Comput Struct Biotechnol J, 13, 448-58. crossref(new window)

10.
Lordick F, Siewert JR (2006). [Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study]. Chirurg, 77, 1166-7. crossref(new window)

11.
Park JK, Lee SH, Kang JH, et al (2004). Synergistic interaction between gefitinib (Iressa, ZD1839) and paclitaxel against human gastric carcinoma cells. Anticancer Drugs, 15, 809-18. crossref(new window)

12.
Pinedo HM, Peters GF (1988). Fluorouracil: biochemistry and pharmacology. J Clin Oncol, 6, 1653-64. crossref(new window)

13.
Suttie SA, Park KG, Smith TA (2007). [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil. Br J Cancer, 97, 902-9. crossref(new window)

14.
Tsugane S, Sasazuki S, Kobayashi M, et al (2004). Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer, 90, 128-34. crossref(new window)

15.
Weinreich J, Archid R, Bajaeifer K, et al (2015). Growth and Chemosensitivity of Gastric Adenocarcinoma and Non-Malignant Cell Lines in Response to Novel Anti-Cancer Drug Combinations. Chemotherapy, 60, 346-52. crossref(new window)

16.
Yamane N, Makino M, Kaibara N (1999). S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells. Cancer, 85, 309-17. crossref(new window)

17.
Zoli W, Ricotti L, Tesei A, et al (2004). Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro. Clin Cancer Res, 10, 1500-7. crossref(new window)